The store will not work correctly when cookies are disabled.
ethyl 4-(benzylselanyl)-6-methoxyquinoline-2-carboxylate
ID: ALA4642799
PubChem CID: 156016152
Max Phase: Preclinical
Molecular Formula: C20H19NO3Se
Molecular Weight: 400.34
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)c1cc([Se]Cc2ccccc2)c2cc(OC)ccc2n1
Standard InChI: InChI=1S/C20H19NO3Se/c1-3-24-20(22)18-12-19(25-13-14-7-5-4-6-8-14)16-11-15(23-2)9-10-17(16)21-18/h4-12H,3,13H2,1-2H3
Standard InChI Key: IVWKITJYTRIMPS-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
3.4737 -22.3448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4726 -23.1643 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1806 -23.5733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1788 -21.9359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8874 -22.3412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8882 -23.1602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5967 -23.5673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3050 -23.1564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3003 -22.3343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5912 -21.9309 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5984 -24.3844 0.0000 Se 0 0 0 0 0 2 0 0 0 0 0 0
7.0055 -21.9214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7157 -22.3257 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.0005 -21.1042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.4209 -21.9128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1310 -22.3171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7645 -23.5723 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.0571 -23.1632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3070 -24.7916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3087 -25.6088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6013 -26.0133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6027 -26.8297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3118 -27.2377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0210 -26.8232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0161 -26.0081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
7 11 1 0
9 12 1 0
12 13 1 0
12 14 2 0
13 15 1 0
15 16 1 0
2 17 1 0
17 18 1 0
11 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 400.34 | Molecular Weight (Monoisotopic): 401.0530 | AlogP: ┄ | #Rotatable Bonds: ┄ |
Polar Surface Area: ┄ | Molecular Species: ┄ | HBA: ┄ | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): ┄ | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: ┄ | CX LogD: ┄ |
Aromatic Rings: ┄ | Heavy Atoms: ┄ | QED Weighted: ┄ | Np Likeness Score: ┄ |
References
1. Costa CA, Lopes RM, Ferraz LS, Esteves GNN, Di Iorio JF, Souza AA, de Oliveira IM, Manarin F, Judice WAS, Stefani HA, Rodrigues T.. (2020) Cytotoxicity of 4-substituted quinoline derivatives: Anticancer and antileishmanial potential., 28 (11): [PMID:32336669] [10.1016/j.bmc.2020.115511] |